What We're Reading: Page 117
Industry reads hand-picked by our editors
Dec 05, 2022
-
The Wall Street Journal
Why You Can’t Find Wegovy, the Weight-Loss Drug
-
STAT
AAM’s Dan Leonard, president of generic drug lobby, ousted
-
Reuters
Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5
-
Financial Times
DeepMind spin-off steps up effort to use AI to create new drugs
Dec 02, 2022
Dec 01, 2022
-
Reuters
J&J sues Amgen over plan to sell drug similar to blockbuster Stelara
-
Boston Business Journal
What’s at stake in the battle over rights to Covid-19 vaccines
-
The Wall Street Journal
Biotech Company Says Citadel, Other Big Traders Manipulated Its Stock Price
Nov 30, 2022
Nov 29, 2022
-
The Wall Street Journal
Nestlé May Shed Peanut Allergy Treatment as Sales Disappoint
-
Financial Times
Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug
-
Bloomberg
China Aims to Boost Elderly Covid Vaccination Amid Reopening Pressure
-
Axios
Standalone drug plans broached for frail seniors in community-based care
Previous
